Cannabis use amongst adolescents has been associated with increased risk of depression and anxiety in adulthood, according to a new study.
In the largest study of its kind, researchers have revealed that individuals who exercise report having fewer days of poor mental health than those who do not exercise.
In an international collaboration, researchers have determined that psychiatric disorders may have important molecular similarities that are not reflected in current diagnostic categories.
Over a third of adults in the USA may be unknowingly using prescription medications that could increase the risk of depression and suicide.
Efficacy and metabolic effects of lurasidone versus brexpiprazole in schizophrenia: a network meta-analysis
In this research article from Journal of Comparative Effectiveness Research, a new network meta-analysis compares lurasidone and brexpiprazole in acute schizophrenia.
A new study has revealed that a nasal spray formulation of ketamine demonstrates promise in the rapid treatment of symptoms of major depression and suicidal thoughts.
A recent study has reported that long-term consumption of caffeine has negative effects for Alzheimer’s disease, potentially worsening the neuropsychiatric symptoms in those affected by the disorder.
This review article from Journal of Comparative Effectiveness Research explores the use of tetrabenazine and valbenazine in treating tardive dyskinesia (TD), a movement disorder often induced by antipsychotic drugs.
CYP2D6 and CYP2C19 genotyping in psychiatric patients on psychotropic medication in the former Dutch Antilles
In this research article from Pharmacogenomics discover the prevalence of CYP2D6 and CYP2C19 polymorphisms in psychiatric patients and volunteers from Dutch caribbean origin.
A new study has shown that individuals with schizophrenia are dying earlier and at a higher rate than those without schizophrenia.